ArticleDiabetologia2012

Beneficial effects of the novel cholecystokinin agonist (pGlu-Gln)-CCK-8 in mouse models of obesity/diabetes.

N Irwin et al.PubMed ↗Publisher ↗

No numbers read from the abstract.